Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,048Revenue $M37.0Net Margin (%)-163.7Z-Score-3.4
Enterprise Value $M953EPS $-0.3Operating Margin %-284.8F-Score1
P/E(ttm))0Cash Flow Per Share $-0.6Pre-tax Margin (%)-163.7Higher ROA y-yN
Price/Book20.210-y EBITDA Growth Rate %-29.4Quick Ratio2.5Cash flow > EarningsN
Price/Sales25.95-y EBITDA Growth Rate %-45.7Current Ratio2.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-18.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-68.1Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M220ROI % (ttm)-11.9Gross Margin Increase y-yN

Gurus Latest Trades with ARNA

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

ARNA is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ARNA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SPECTOR STEVEN WEVP, General Counsel & Sec 2015-03-17Sell70,000$5-13.2view
SPECTOR STEVEN WEVP, General Counsel & Sec 2015-01-08Sell45,000$6.26-30.67view
SHANAHAN WILLIAM R JRSVP & Chief Medical Officer 2015-01-07Sell50,000$5.49-20.95view
LIEF JACKChairman, President and CEO 2014-07-01Sell223,525$5.85-25.81view
BELCHER DONALD DDirector 2014-06-27Sell2,473$5.85-25.81view
SPECTOR STEVEN WEVP, General Counsel & Sec 2014-05-12Sell45,000$7.05-38.44view
BELCHER DONALD DDirector 2014-05-06Sell4,176$7-38view
HIXSON HARRY F JRDirector 2014-04-22Sell36,900$6.31-31.22view
Nova Tina SusanDirector 2014-04-14Sell35,000$6.22-30.23view
BELCHER DONALD DDirector 2014-04-01Sell1,905$6.45-32.71view

Press Releases about ARNA :

    Quarterly/Annual Reports about ARNA:

    News about ARNA:

    Articles On GuruFocus.com
    Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
    (ARNA) Initiated with a Buy, (ICLD, FONR) Strong Performance on Financial Results Nov 16 2013 
    WEEKLY CFO SELLS HIGHLIGHT: ZNGA, ARNA, JACK, TUMI, PANW Apr 07 2013 
    comment on ARNA Mar 16 2013 
    comment on ARNA Mar 02 2013 
    WEEKLY CFO SELLS HIGHLIGHT: QCOM, RA, ARNA, ATU, DGX, MSCC Oct 07 2012 
    Arena Facing Increased Pressure from Peers Apr 23 2012 
    Arena Could Dip If Lorcaserin Fails Again Apr 22 2012 
    Vivus Could Rocket on Success of Qnexa Apr 13 2012 
    These 4 Biotech Stocks Are a Buy Now Feb 08 2012 

    More From Other Websites
    Zacks Rank #5 Additions for Thursday - Tale of the Tape Mar 19 2015
    Zacks Rank #5 Additions for Wednesday - Tale of the Tape Mar 11 2015
    Novo Nordisk's Saxenda: New Data from Phase IIIa Study - Analyst Blog Mar 09 2015
    Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2014... Mar 07 2015
    Is Arena Pharmaceuticals In Trouble? Mar 05 2015
    Biotech Stock Roundup: Orexigen Soars on Contrave Data, Amgen Scores in Study - Analyst Blog Mar 04 2015
    Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2014 Financial Results Conference Call... Mar 04 2015
    ARENA PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure Mar 03 2015
    Orexigen Soars On Obesity Drug's Surprise Health Boon Mar 03 2015
    Orexigen Weight-Loss Pill Shows Surprise Heart-Safety Benefit Mar 03 2015
    Arena Pharmaceuticals' Q4 Loss Wider than Expected - Analyst Blog Mar 03 2015
    Arena Pharmaceuticals Misses Q4 Expectations Mar 02 2015
    Arena Pharmaceuticals reports 4Q loss Mar 02 2015
    Arena Pharmaceuticals reports 4Q loss Mar 02 2015
    Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2014... Mar 02 2015
    Will Arena Pharmaceuticals (ARNA) Disappoint on Q4 Earnings? - Analyst Blog Feb 27 2015
    Arena Pharmaceuticals to Present at the 2015 RBC Capital Markets Healthcare Conference Feb 23 2015
    Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2014 Financial Results Conference Call... Feb 23 2015
    Sporting Goods Stores Arena and New Balance to Open in SEC RayON Feb 23 2015
    Obesity Drugs: Orexigen Gains Market Share at Expense of Arena, Vivus Feb 20 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK